Abstract
Previous experiments on primary cultures of hippocampal/cortical neurones revealed that the block and unblock of N-Methyl-d-Aspartate (NMDA) receptor channels by memantine showed double exponential kinetics and that the offset kinetics following a voltage-step were much faster than following a concentration jump. There are, however, two major problems when using such cultured primary neurones for these experiments (1) the almost certain expression of heterogeneous NMDA receptor subunits which could underlie double exponential kinetics due to different potencies at receptor subtypes and (2) slow space- and concentration-clamp due to neuronal morphology which could mask even faster kinetics. Therefore, we performed similar experiments with Xenopus oocytes exclusively expressing one NMDA receptor type (NR1a/2A) at high levels which allowed recordings from membrane patches with large currents. The use of inside-out patches for voltage-step and outside-out patches in combination with a piezo driven fast application system largely negated potential space- and concentration-clamp problems. Block and unblock of the NMDA receptor by memantine after both voltage jump and concentration jumps showed triple exponential kinetics. The fast onset kinetics of NMDA receptor channel block following both concentration-clamp and voltage jumps from +70 to −70 mV were similar. In contrast, offset kinetics after a voltage-step from −70 to +70 mV were much faster than following a concentration jump at the holding potential of −70 mV. These results provide further support for the hypothesis that rapid relief of block via strong synaptic membrane depolarisation underlies the good therapeutic profile of memantine.
Similar content being viewed by others
References
Blanpied TA, Boeckman FA, Aizenman E, Johnson JW (1997) Trapping channel block of NMDA-activated responses by amantadine and memantine. J Neurophysiol 77:309–323
Blanpied TA, Clarke RJ, Johnson JW (2005) Amantadine inhibits NMDA receptors by accelerating channel closure during channel block. J Neurosci 25:3312–3322
Bresink I, Benke TA, Collett VJ, Seal AJ, Parsons CG, Henley JM, Collingridge GL (1996) Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br J Pharmacol 119:195–204
Buéno L, Eutamene H, Beufrand C (2007) Comparative effects of glycine B selective antagonists on LPS induced visceral hypersensitivity in rats.
Chen HSV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA (1992) Open-channel block of N-Methyl-d-Aspartate (NMDA) responses by memantine—therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12:4427–4436
Danysz W, Parsons CG (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease preclinical evidence. Int J Geriatr Psychiatry 18:S23–S32
Danysz W, Parsons CG, Möbius HJ, Stöffler A, Quack G (2000) Neuroprotective and symptomatological action of memantine relevant for Alzheimer′s disease—an unified glutamatergic hypothesis on the mechanism of action. Neurotox Res 2:85–97
Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM, Bell JM (2005) Meta-analysis of 6-month memantine clinical trials in Alzheimer’s disease. Ann Neurol 58(Supp 9):49–50
Frankiewicz T, Potier B, Bashir ZI, Collingridge GL, Parsons CG (1996) Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices. Br J Pharmacol 117:689–697
Gilling KE, Jatzke C, Parsons CG (2007) Agonist concentration-dependency of blocking kinetics but not equilibrium block of N-Methyl-d-Aspartate receptors by memantine. Neuropharmacology 53:415–420
Green T, Rogers CA, Contractor A, Heinemann SF (2002) NMDA receptors formed by NR1 in Xenopus laevis oocytes do not contain the endogenous subunit XenU1. Mol Pharmacol 61:326–333
Kornhuber J, Bormann J, Hubers M, Rusche K, Riederer P (1991) Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA receptor-gated ion channel—a human postmortem brain study. Eur J Pharmacol 206:297–300
Kornhuber J, Bormann J, Retz W, Hubers M, Riederer P (1989) Memantine displaces [< 3>H] MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166:589–590
Laube B, Schemm R, Betz H (2004) Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor. Neuropharmacology 47:994–1007
Li WM, Kan KK, Carlier PR, Pang YP, Han YF (2007) East meets west in the search for Alzheimer’s therapeutics—novel dimeric inhibitors from tacrine and huperzine a. Curr Alzheimer Res 4:386–396
McShane R, Areosa Sastre A, Minakaran N (2006) Memantine for dementia. Cochrane Database Syst Rev CD003154
Parsons CG, Danysz W, Bartmann A, Spielmanns P, Frankiewicz T, Hesselink M, Eilbacher B, Quack G (1999a) Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization. Neuropharmacology 38:85–108
Parsons CG, Danysz W, Quack G (1999b) Memantine is a clinically well tolerated N-Methyl-d-Aspartate (NMDA) receptor antagonist—a review of preclinical data. Neuropharmacology 38:735–767
Parsons CG, Gruner R, Rozental J, Millar J, Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-Methyl-d-Aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32:1337–1350
Parsons CG, Hartmann S, Spielmanns P (1998) Budipine is a low affinity, N-Methyl-d-Aspartate receptor antagonist: patch clamp studies in cultured striatal, hippocampal, cortical and superior colliculus neurones. Neuropharmacology 37:719–727
Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S, Danysz W (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 34:1239–1258
Peskind ER, Potkin SG, Pomara N, Ott BR, Graham SM, Olin JT, McDonald S (2006) Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am J Geriatr Psychiatry 14:704–715
Rammes G, Swandulla D, Spielmanns P, Parsons CG (1998) Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones. Neuropharmacology 37:1299–1320
Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ (2003) Memantine in moderate-to-severe Alzheimer’s disease. N Engl J Med 348:1333–1341
Rogawski MA (1993) Therapeutic potential of excitatory amino acid antagonists - channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14:325–331
Schmidt C, Werner M, Hollmann M (2006) Revisiting the postulated “unitary glutamate receptor”: electrophysiological and pharmacological analysis in two heterologous expression systems fails to detect evidence for its existence. Mol Pharmacol 69:119–129
Sobolevsky A, Koshelev S (1998) Two blocking sites of amino-adamantane derivatives in open N-Methyl-d-Aspartate channels. Biophys J 74:1305–1319
Sobolevsky AI, Koshelev SG, Khodorov BI (1998) Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons. J Physiol (Lond) 512(Pt 1):47–60
Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291:317–324
Wang LY, Macdonald JF (1995) Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones. J Physiol 486:83–95
Wang LY, Orser BA, Jia Z, Roder J, Macdonald JF (1994) Magnesium and ketamine increase the affinity of NMDA receptors for glycine. 24th Society for Neuroscience Annual Meeting. Soc Neurosci Abst 20:734
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parsons, C.G., Gilling, K.E. & Jatzke, C. Blocking kinetics of memantine on NR1a/2A receptors recorded in inside-out and outside-out patches from Xenopus oocytes. J Neural Transm 115, 1367–1373 (2008). https://doi.org/10.1007/s00702-008-0087-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-008-0087-7